-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JjJD8JP8rvS61c2BC+aDcAn080yMYmM6sZG9nRzvWQZ/cyIXGfaOs5zMSYEShzSR GmP5mOX2ehxIlLVddvS6jA== 0001209191-05-036645.txt : 20050712 0001209191-05-036645.hdr.sgml : 20050712 20050712101114 ACCESSION NUMBER: 0001209191-05-036645 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20021106 FILED AS OF DATE: 20050712 DATE AS OF CHANGE: 20050712 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TARGETED GENETICS CORP /WA/ CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 OLIVE WAY STREET 2: STE 100 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 2066237612 MAIL ADDRESS: STREET 1: 1100 OLIVE WAY STREET 2: STE 100 CITY: SEATTLE STATE: WA ZIP: 98101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOGEN IDEC MA INC CENTRAL INDEX KEY: 0000714655 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23930 FILM NUMBER: 05949489 BUSINESS ADDRESS: STREET 1: 14 CAMBRIDGE CTR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-679-2000 MAIL ADDRESS: STREET 1: 14 CAMBRIDGE CTR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER NAME: FORMER CONFORMED NAME: BIOGEN INC DATE OF NAME CHANGE: 19920703 FORMER NAME: FORMER CONFORMED NAME: BIOGEN NV DATE OF NAME CHANGE: 19880622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOGEN IDEC INC CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23930 FILM NUMBER: 05949490 BUSINESS ADDRESS: STREET 1: 11011 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195508500 MAIL ADDRESS: STREET 1: 11011 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER NAME: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 4 1 b55794ra4.xml MAIN DOCUMENT DESCRIPTION X0202 4 2002-11-06 0000921114 TARGETED GENETICS CORP /WA/ TGEN 0000875045 BIOGEN IDEC INC 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 0 0 1 0 0000714655 BIOGEN IDEC MA INC 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 0 0 1 0 Common Stock, $0.01 Par Value 2002-09-30 4 J 0 104854 .55 A 9400516 I By Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2002-11-06 4 J 0 210819 1.07 D 9611335 I By Biogen Idec MA, Inc. Common Stock, $0.01 Par Value 2003-08-15 4 P 0 2515843 1.91 A 12127178 I By Biogen Idec MA, Inc. The reporting person received these shares as additional merger consideration for its preferred shares of Genovo, Inc. exchanged in the merger of a subsidiary of Targeted Genetics Corporation with and into Genovo on September 19, 2000, pursuant to the exercise of the Genzyme Corporation's stock option in connection with the merger. Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA, Inc., fka Biogen, Inc. The reporting person forfeited these shares on 11/6/2002 to Targeted Genetics in connection with certain of its indemnification claims under the Agreement and Plan of Merger, dated August 8, 2000, among Genovo, Inc., Targeted Genetics, a wholly-owned subsidiary of Targeted Genetics and the reporting person, a stockholder of Genovo. The reporting person purchased these shares on 8/15/2003 upon exercise by Targeted Genetics of its right to put such shares to the reporting person for purchase under the Funding Agreement dated as of August 8, 2000 between Targeted Genetics and the reporting person. Exhibit List Exhibit 99- Joint Filer Information /s/ Raymond G. Arner, Acting General Counsel 2005-07-12 EX-99 2 exhibit99form4.txt ADDITIONAL EXHIBITS Exhibit 99 Form 4 Joint Filer Information Name: Biogen Idec MA, Inc. Address: 14 Cambridge Center Cambridge, Massachusetts 02142 Designated Filer: Biogen Idec Inc. Issuer and Ticker Symbol: Targeted Genetics Corporation (TGEN) Date of Earliest Transaction Required to be Reported: September 30, 2002 Signature: By: /s/ Michael Phelps Name: Michael Phelps Title: Treasurer -----END PRIVACY-ENHANCED MESSAGE-----